{"id":92135,"date":"2019-06-15T16:42:50","date_gmt":"2019-06-15T23:42:50","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/06\/first-human-clinical-trial-results-on-the-anti-aging-compound-urolithin-a-published"},"modified":"2019-06-15T16:42:50","modified_gmt":"2019-06-15T23:42:50","slug":"first-human-clinical-trial-results-on-the-anti-aging-compound-urolithin-a-published","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/06\/first-human-clinical-trial-results-on-the-anti-aging-compound-urolithin-a-published","title":{"rendered":"First Human Clinical Trial Results on the Anti-Aging Compound, Urolithin A, PUblished"},"content":{"rendered":"<p style=\"padding-right: 20px\"><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/first-human-clinical-trial-results-on-the-anti-aging-compound-urolithin-a-published.jpg\"><\/a><\/p>\n<p>LAUSANNE, Switzerland\u2014(BUSINESS WIRE).<\/p>\n<p><b>Breakthrough translational science of dietary supplementation with Urolithin A, a pomegranate metabolite, on mitochondrial and cellular health in humans published in the journal <i>Nature Metabolism<\/i><\/b><\/p>\n<p>Amazentis, an innovative life sciences company pioneering scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in <i>Nature Metabolism<\/i> with scientists at the \u00c9cole Polytechnique F\u00e9d\u00e9rale de Lausanne (EPFL) and the Swiss Institute of Bioinformatics (SIB) demonstrating the Company\u2019s lead product, Urolithin A (UA), is safe, bioavailable and improves mitochondrial and cellular health in humans.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LAUSANNE, Switzerland\u2014(BUSINESS WIRE). Breakthrough translational science of dietary supplementation with Urolithin A, a pomegranate metabolite, on mitochondrial and cellular health in humans published in the journal Nature Metabolism Amazentis, an innovative life sciences company pioneering scientific breakthroughs in nutrition to manage health conditions linked to aging, announced today a collaborative publication in Nature Metabolism with [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,43,269],"tags":[],"class_list":["post-92135","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-business","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/92135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=92135"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/92135\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=92135"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=92135"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=92135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}